Correlation Between Bioventus and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bioventus and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioventus and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bioventus and Neuropace, you can compare the effects of market volatilities on Bioventus and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioventus with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioventus and Neuropace.

Diversification Opportunities for Bioventus and Neuropace

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bioventus and Neuropace is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Bioventus and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Bioventus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioventus are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Bioventus i.e., Bioventus and Neuropace go up and down completely randomly.

Pair Corralation between Bioventus and Neuropace

Considering the 90-day investment horizon Bioventus is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, Bioventus is 1.72 times less risky than Neuropace. The stock trades about -0.13 of its potential returns per unit of risk. The Neuropace is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest  590.00  in Neuropace on August 24, 2024 and sell it today you would earn a total of  310.00  from holding Neuropace or generate 52.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bioventus  vs.  Neuropace

 Performance 
       Timeline  
Bioventus 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bioventus are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Bioventus unveiled solid returns over the last few months and may actually be approaching a breakup point.
Neuropace 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Bioventus and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bioventus and Neuropace

The main advantage of trading using opposite Bioventus and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioventus position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind Bioventus and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules